Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 19/20 | 1.00 |
| ▸ | PIK3CD | O00329 | 15/20 | 1.00 |
| ▸ | ABL1 | P00519 | 15/20 | 1.00 |
| ▸ | PIK3CA | P42336 | 15/20 | 1.00 |
| ▸ | PIK3CB | P42338 | 15/20 | 1.00 |
| ▸ | PIK3CG | P48736 | 15/20 | 1.00 |
| ▸ | PRKDC | P78527 | 15/20 | 1.00 |
| ▸ | MTOR | P42345 | 15/20 | 1.00 |
| ▸ | EGFR | P00533 | 14/20 | 1.00 |
| ▸ | HCK | P08631 | 14/20 | 1.00 |
| ▸ | KDR | P35968 | 14/20 | 1.00 |
| ▸ | EPHB4 | P54760 | 14/20 | 1.00 |
| ▸ | PI4KB | Q9UBF8 | 3/20 | 1.00 |
| ▸ | BACE1 | P56817 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391405 | 0.86 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL14574867 | 0.86 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL3615741 | 0.85 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL14574639 | 0.85 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL29390634 | 0.85 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL3610356 | 0.83 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL14617304 | 0.82 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL18196381 | 0.81 | SRC (0.80) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL17962818 | 0.80 | SRC (0.74) | SRCPIK3CDABL1PIK3CAPIK3CB | |
| SCHEMBL2468132 | 0.80 | SRC (1.00) | SRCPIK3CDABL1PIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |